Bausch + Lomb

Update in progress

BLCO (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

Bausch + Lomb is an eye health company with operations in the United States, Canada, Europe, Asia, and beyond. It has three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care includes contact lenses (daily disposables, therapeutic lenses), lens care products, eye vitamins, minerals, and OTC drops for allergies, dry eye, and redness. Pharmaceuticals covers branded and generic eye medicines; Surgical provides devices and instruments for cataract, corneal, vitreous, and retinal procedures and intraocular lenses. The company sells through direct sales and distributors. Founded in 1853, it is based in Vaughan, Canada, and is a subsidiary of Bausch Health Companies Inc.

Company score

Sentiment: 0.71; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.68; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.37; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.06; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.35; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.53; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive